Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)

Last updated: March 11, 2020
Sponsor: University Hospital, Angers
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lupus

Immune (Idiopathic) Thrombocytopenic Purpura (Itp)

Immune Thrombocytopenia (Itp)

Treatment

N/A

Clinical Study ID

NCT03123497
49RC17_0011
  • Ages 1-17
  • All Genders

Study Summary

Assessment of quality of life of patient with chronic idiopathic thrombocytopenic purpura according to the type of treatment

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • children with Idiopathic thrombocytopenic purpura

  • aged between 1 and 17 year

  • Idiopathic thrombocytopenic purpura persistent at 12 months

  • obtention of informed consent

Exclusion

Exclusion Criteria:

  • Persistant/acute Idiopathic thrombocytopenic purpura

  • concomittant chronic disease, stabilized or not

  • Concomittant disease with life expectancy < 1 year

  • Person who have not belong to a social security scheme

  • Secondary Idiopathic thrombocytopenic purpura

Study Design

Total Participants: 183
Study Start date:
April 12, 2017
Estimated Completion Date:
October 30, 2020

Connect with a study center

  • CHU d'Angers

    Angers, 49933
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.